• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.10% Nasdaq Up 0.08%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    6.08 Down 0.98(13.84%) 12:15PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.06
    Open:6.99
    Bid:6.15 x 100
    Ask:6.16 x 200
    1y Target Est:13.83
    Beta:1.89
    Next Earnings Date:N/A
    Day's Range:6.06 - 6.99
    52wk Range:3.05 - 8.61
    Volume:427,610
    Avg Vol (3m):327,216
    Market Cap:235.50M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTK

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 13.84%235.50M
    BIIBUp 1.31%74.65B
    LGNDDown 0.13%2.10B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.10
    Quarterly EPS Est (Sep-15) :-0.31
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback